Benjamin Edwards Inc. decreased its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 68.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,245 shares of the company's stock after selling 26,771 shares during the period. Benjamin Edwards Inc.'s holdings in Nutrien were worth $590,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Bank of Montreal Can boosted its stake in Nutrien by 15.5% in the 2nd quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock worth $719,668,000 after purchasing an additional 1,794,333 shares during the period. Silchester International Investors LLP boosted its position in shares of Nutrien by 164.4% during the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock worth $513,437,000 after acquiring an additional 6,642,075 shares during the last quarter. 1832 Asset Management L.P. grew its stake in Nutrien by 1.9% during the second quarter. 1832 Asset Management L.P. now owns 9,006,528 shares of the company's stock valued at $458,522,000 after acquiring an additional 167,312 shares in the last quarter. Altshuler Shaham Ltd grew its stake in Nutrien by 8.1% during the second quarter. Altshuler Shaham Ltd now owns 5,990,374 shares of the company's stock valued at $304,970,000 after acquiring an additional 446,340 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Nutrien by 8.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,145,375 shares of the company's stock valued at $261,985,000 after acquiring an additional 399,348 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on NTR shares. UBS Group cut Nutrien from a "buy" rating to a "neutral" rating and cut their price target for the company from $66.00 to $51.00 in a report on Thursday, October 10th. Wells Fargo & Company lowered shares of Nutrien from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $62.00 to $50.00 in a report on Tuesday, September 24th. Barclays decreased their price target on shares of Nutrien from $68.00 to $55.00 and set an "overweight" rating on the stock in a research note on Friday, August 16th. TD Securities dropped their price objective on shares of Nutrien from $63.00 to $61.00 and set a "buy" rating for the company in a research note on Tuesday, November 12th. Finally, The Goldman Sachs Group cut shares of Nutrien from a "buy" rating to a "neutral" rating and decreased their target price for the company from $69.00 to $53.00 in a research report on Tuesday, September 10th. Three research analysts have rated the stock with a sell rating, four have given a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Nutrien presently has a consensus rating of "Hold" and a consensus target price of $60.06.
Read Our Latest Research Report on Nutrien
Nutrien Trading Down 0.3 %
NTR stock traded down $0.15 during midday trading on Friday, reaching $47.93. The company's stock had a trading volume of 1,544,052 shares, compared to its average volume of 1,993,113. Nutrien Ltd. has a 1 year low of $44.65 and a 1 year high of $60.87. The firm has a market capitalization of $23.67 billion, a price-to-earnings ratio of 32.17, a PEG ratio of 1.70 and a beta of 0.80. The stock has a fifty day simple moving average of $47.96 and a two-hundred day simple moving average of $49.33. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.43 by ($0.04). The company had revenue of $5.35 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The company's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.35 EPS. On average, equities research analysts predict that Nutrien Ltd. will post 3.54 EPS for the current year.
Nutrien Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be issued a $0.939 dividend. This is a positive change from Nutrien's previous quarterly dividend of $0.54. The ex-dividend date is Tuesday, December 31st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.84%. Nutrien's payout ratio is presently 144.97%.
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.